KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20 | -25.9% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $27 | -53.4% | 15,000 | 0.0% | 0.00% | -66.7% |
Q1 2023 | $58 | -65.9% | 15,000 | +175.2% | 0.00% | -66.7% |
Q4 2022 | $170 | -99.9% | 5,450 | 0.0% | 0.01% | -43.8% |
Q3 2022 | $274,000 | +21.2% | 5,450 | 0.0% | 0.02% | +33.3% |
Q2 2022 | $226,000 | -38.6% | 5,450 | 0.0% | 0.01% | -25.0% |
Q1 2022 | $368,000 | +161.0% | 5,450 | +2377.3% | 0.02% | +220.0% |
Q4 2021 | $141,000 | -66.3% | 220 | -99.6% | 0.01% | -73.7% |
Q3 2021 | $419,000 | +35.2% | 50,220 | +151.1% | 0.02% | +11.8% |
Q4 2020 | $310,000 | +6.2% | 20,000 | 0.0% | 0.02% | -10.5% |
Q3 2020 | $292,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |